Pulmonx(LUNG) - 2023 Q4 - Earnings Call Presentation
Pulmonx(LUNG)2024-02-22 02:01© 2024 Pulmonx Corporation1 © 2024 Pulmonx Corporation | --- | --- | --- | --- | |----------------------------------------------------------------------------|-------|-------|----------------------------------------------------------------| | | | | | | Large Market | | | Broadly Reimbursed | | $12B opportunity for severe emphysema | | | In global guidelines & reimbursed in US, Europe and Australia | | | | | | | Precision Treatment | | | Global Footprint | | Proprietary patient selection technology & minimal ...